Skip to content

As a church-going scientist-turned-writer, I was on the fence about the recent nomination of geneticist Francis Collins to lead the National Institutes of Health. There's …

Published on

Stanford's Irving Weissman, MD, questions who's really in charge of our national embryonic stem cell research policy.

Stanford's Irving Weissman, MD, questions who's really in charge of our national embryonic stem cell research policy.

Published on

Has Douglas Elmemdorf, CBO director, put a nail into the coffin on the notion that the Congress could possibly have a legislative reform package ready …

Published on

Keith Humphreys, PhD, professor of psychiatry and behavioral science, is embarking on a new role this week - that of Senior Policy Advisor at the …

When I asked Stanford health-care economist Victor Fuchs back in 2005 what it would take to significantly reform the U.S. health-care system, he said nothing …

Victor Fuchs, PhD, one of the nation's foremost health economists, says a government-run plan will not solve the huge financial issues that plague health-care in …

Published on

The concept behind comparative effectiveness research seems simple enough. Researchers would compare two or more strategies for treating a specific illness and then determine which …

Federal stimulus funds are beginning to be distributed, and among the initial awards from the National Institutes of Health are 18 projects at Stanford, ranging …

Kaiser Health News, a news service from Kaiser Family Foundation, launched today, and Bob Laszewski at Health Care Policy and Marketplace Review is an early …

Some health care activists are frustrated that a single-payer system isn't being seriously considered by those tackling health care reform in Washington. An interesting article …

The first hour of yesterday's Forum (on KQED-FM) was dedicated to women's health and the NIH's attempts to establish research priorities in this area. That …

Researchers at Stanford and across the country are rushing to file their proposals for the NIH's Challenge Grant Program. The $200-million program, established as part …

Three years ago, I had the chance to interview Susan Wood, former director of the FDA Office of Women's Health, about that agency's controversial decision …